David I. Scheer

Founder at Scheer & Co., Inc.

David I. Scheer

David I. Scheer

Founder at Scheer & Co., Inc.

Overview
Career Highlights

Scheer & Co., Inc.
Aegerion Pharmaceuticals Inc.
Tengion, Inc.

RelSci Relationships

1798

Number of Boards

13

Birthday

1953

Age

66

Relationships
RelSci Relationships are individuals David I. Scheer likely has professional access to. A relationship does not necessarily indicate a personal connection.

Founder at Sopherion Therapeutics LLC

Relationship likelihood: Strong

Founder at AMV Advisors

Relationship likelihood: Strong

Founder at Global Biolink Partners

Relationship likelihood: Strong

SEE Schedule at Methodist Hospital Group

Relationship likelihood: Strong

Managing Director, Venture Capital Investments at Connecticut Innovations, Inc.

Relationship likelihood: Strong

President & Director at Aegerion Pharmaceuticals Inc.

Relationship likelihood: Strong

Former Technology Director at Yale University

Relationship likelihood: Strong

Former Vice President-Sales & Marketing at Prolacta Bioscience, Inc.

Relationship likelihood: Strong

Visiting Scientist at National Institutes of Health

Relationship likelihood: Strong

Co-Chairman & Treasurer at Connecticut United for Research Excellence, Inc.

Relationship likelihood: Strong

Paths to David I. Scheer
Potential Connections via
Relationship Science
You
David I. Scheer
Founder at Scheer & Co., Inc.
Education
MS

Yale University is an American private Ivy League research university located in New Haven, Connecticut. Founded in 1701 in the Colony of Connecticut, the university is the third-oldest institution of higher education in the United States.

AB, cum laude

The oldest corporation in the Western Hemisphere is the Harvard Corporation, known formally as the President and Fellows of Harvard College. It is the smaller of Harvard’s two governing boards; the other is the Board of Overseers. Following are the members of the Harvard Corporation.

Career History
Founder
1981 - Current

Scheer & Co. focuses on private equity and venture capital investments in the life sciences and healthcare sectors. The firm participates in growth financings, in-licensings, out-licensings, asset divestments, spin-offs and mergers and acquisitions, as well as investments in start-up companies and the commercialization of research from academic institutions.

Director
1996 - 2003

OraPharma, Inc. develops and produces drugs for oral diseases. It offers a suite of products to address a range of patient concerns from the foundation of gums, bone, and teeth to the aesthetics of a whiter smile. The company's products include ARESTIN Microspheres, a locally administered antibiotic indicated as an adjunct to scaling and root planning procedures for the reduction of pocket depth in patients with adult periodontitis; and ONSET Approach, a unique delivery system of locally buffered anesthesia that provides faster onset of anesthesia and a comfortable injection. The company was founded in 1996 and is headquartered in Horsham, PA.

Co-Founder
2003 - 2014

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

Boards & Committees
Independent Chairman of the Board
2003 - Current

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

Member, Board of Directors
1998 - Current

Achillion Pharmaceuticals, Inc. engages in the discovery and development of small molecule drug therapies for immune system disorders. It offers its propriety platform of potent and specific complement factor D inhibitors for AP-mediated diseases. The company was founded on August 17, 1998 and is headquartered in New Haven, CT.

Director
2010 - 2016

Angiochem, Inc. is a clinical-stage biotechnology company, which engages in the development of pharmaceutical drugs for brain diseases and brain-related disorders. It offers small molecules and biologics, for the treatment of central nervous system diseases including primary brain cancer, brain metastases, lysosomal storage diseases, and pain. The company founded by Richard Béliveau in 2003 and is headquartered in Montreal, Canada.

Director
2007 - Current

Connecticut United for Research Excellence, Inc. intends to promote public understanding on the benefits of vaccines and medicines that are being offered by bioscience companies. Its members include biomedical research and educational institutions, biotechnology companies, health professionals, and healthcare systems. The company was founded on August 31, 1990 and is headquartered in New Haven, CT.

Chair, Unfinished Agenda in Infectious Diseases
Current

The Harvard School of Public Health (HSPH) is one of the professional graduate schools of Harvard University, located in the Longwood Area of Boston, Massachusetts neighborhood of Mission Hill, which is next to Harvard Medical School. HSPH is considered a significant school focusing on health in the United States. Harvard School of Public Health grew out of the Harvard-MIT School for Health Officers, the nation's first graduate training program in population health, which was founded in 1913 and became Harvard School of Public Health in 1922. Julio Frenk, the Minister of Health of Mexico from 2000 to 2006 and a former executive director of the World Health Organization (WHO), became the new dean of HSPH in January 2009.

Vice Chair
Prior

TO CREATE THEATRE OF THE HIGHEST QUALITY THAT INSPIRES DISCOURSE AND REFLECTION ABOUT EACH OF US AND THE WORLD WE LIVE IN.

Transactions
Details Hidden

Renetx Bio, Inc. raised money in a private placement transaction

Investments
Details Hidden

Aegerion Pharmaceuticals, Inc. operates as a biopharmaceutical company. It engages in the development and commercialization of therapies for patients with debilitating rare diseases. The company was founded by David I. Scheer and William H. Lewis on January 5, 2011 and is headquartered in Cambridge, MA.

Details Hidden

Tengion, Inc. is a medicine company, focuses on discovering, developing, manufacturing and commercializing of neo-organs and products. The company was founded by Steven Nichtberger and David I. Scheer on July 10, 2003 and is headquartered in Winston-Salem, NC.

Details Hidden

Sopherion Therapeutics LLC develops and commercializes anti-cancer therapies. The company was founded by Ronald H. Goldfarb and Salvatore Forenza in 2002 and is headquartered in Princeton, NJ.

Public Holdings
Restricted data only for RelSci Professional users.
This web site is not endorsed by, directly affiliated with, maintained, authorized, or sponsored by David I. Scheer. The use of any trade name or trademark is for identification and reference purposes only and does not imply any association with the trademark holder. The Presence of David I. Scheer's profile does not indicate a business or promotional relationship of any kind between RelSci and David I. Scheer.